{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:41:25Z","timestamp":1791240085809,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/EDG\/0002\/2007"],"award-info":[{"award-number":["NMRC\/EDG\/0002\/2007"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ygyno.2010.07.028","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T04:52:29Z","timestamp":1281761549000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy"],"prefix":"10.1016","volume":"119","author":[{"given":"Elaine H.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Len","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ilancheran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee Chong","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Hseon","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.07.028_bb0005","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0010","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0015","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0020","article-title":"The accuracy of colposcopic biopsy: analyses from the placebo arm of the gardasil clinical trials","author":"Stoler","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0025","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/1097-0142(19951101)76:9<1601::AID-CNCR2820760916>3.0.CO;2-Z","article-title":"Operator variability in disease detection and grading by colposcopy in patients with mild dysplastic smears","volume":"76","author":"Sideri","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/gyno.1995.1212","article-title":"Observer agreement on interpreting colposcopic images of CIN","volume":"58","author":"Hopman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0035","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2004.02.065","article-title":"Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse","volume":"191","author":"Pretorius","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1067\/mob.2003.456","article-title":"Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study","volume":"188","author":"Guido","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0065","first-page":"17","article-title":"Cervical human papillomavirus infection and intraepithelial neoplasia: a review","volume":"21","author":"Mitchell","year":"1996","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.bjc.6601196","article-title":"HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3","volume":"89","author":"Chan","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/bjc.1989.236","article-title":"Natural history of cervical neoplasia: consistent results obtained by an identification technique","volume":"60","author":"Gustafsson","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ajog.2006.07.036","article-title":"Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less","volume":"195","author":"Pretorius","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0095","first-page":"727","article-title":"Natural history of cervical squamous intraepithelial lesions: a meta-analysis","volume":"92","author":"Melnikow","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0002-9378(97)80017-8","article-title":"Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia","volume":"176","author":"Kaufman","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1109\/TITB.2004.824738","article-title":"Identifying the combination of genetic factors that determine susceptibility to cervical cancer","volume":"8","author":"Horng","year":"2004","journal-title":"IEEE Trans Inf Technol Biomed"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0753-3322(03)00196-3","article-title":"Cigarette smoking and cervical cancer: Part I: a meta-analysis","volume":"57","author":"Haverkos","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0150","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0155","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1045","article-title":"The power and the promise of DNA methylation markers","volume":"3","author":"Laird","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0170","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1158\/1055-9965.EPI-09-0405","article-title":"Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings","volume":"18","author":"Yang","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0175","first-page":"131","article-title":"Gene promoter methylation patterns throughout the process of cervical carcinogenesis","volume":"32","author":"Yang","year":"2010","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2009.09.032","article-title":"Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens","volume":"116","author":"Kim","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ng1598","article-title":"Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells","volume":"37","author":"Weber","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0195","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1126\/science.1080902","article-title":"Loss of IGF2 imprinting: a potential marker of colorectal cancer risk","volume":"299","author":"Cui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cell.2005.07.024","article-title":"Transposons reanimated in mice","volume":"122","author":"Bestor","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0210","article-title":"Genome-wide hypomethylation in cancer may be a passive consequence of transformation","author":"Wild","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1055-9965.EPI-05-0323","article-title":"Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis","volume":"15","author":"Sova","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0230","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-07-3194","article-title":"Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0235","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: a high-throughput assay to measure DNA methylation","volume":"28","author":"Eads","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/meth.2001.1268","article-title":"DNA methylation analysis by MethyLight technology","volume":"25","author":"Trinh","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","article-title":"Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis","volume":"8","author":"Ogino","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.0006-341X.2002.00657.x","article-title":"Combining several screening tests: optimality of the risk score","volume":"58","author":"McIntosh","year":"2002","journal-title":"Biometrics"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0255","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1373\/49.3.433","article-title":"Comparison of eight computer programs for receiver-operating characteristic analysis","volume":"49","author":"Stephan","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0260","first-page":"584","article-title":"Aberrant methylation during cervical carcinogenesis","volume":"7","author":"Virmani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.20425","article-title":"DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis","volume":"102","author":"Gustafson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jnci\/dji041","article-title":"Detection of hypermethylated genes in women with and without cervical neoplasia","volume":"97","author":"Feng","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23258","article-title":"Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests","volume":"114","author":"Kahn","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0280","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0290","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0295","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0305","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/35008000","article-title":"Specificities of heparan sulphate proteoglycans in developmental processes","volume":"404","author":"Perrimon","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2010.07.028_bb0310","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.onc.1206146","article-title":"Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers","volume":"22","author":"Miyamoto","year":"2003","journal-title":"Oncogene"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:24:57Z","timestamp":1758770697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810005573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0090825810005573"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}